Various deletions were introduced into a cloned subgenomic fragment (BamHI-7), located in the unique short (Us) region of the DNA from the virulent Northern Ireland Aujeszky-3 (NIA-3) strain of pseudorabies virus (PRV). In the cloned HindIII-B fragment, the MluI-BglII fragment was replaced by different MluI-BgllI fragments of the deleted BamHI-7 clones. Transfection of the deleted HindIII-B fragments together with the HindlII-A fragment of either the NIA-3 or the non-virulent NIA-4 strain yielded replication-competent deletion mutants. The region in Us in which sequences were deleted specified several mRNAs. Some of the mRNAs present in cells infected with NIA-3 were absent from cells infected with the deletion mutants, whereas other differently sized mRNAs were generated. The mutants were examined with respect to their biological properties in cell culture, mice and pigs. The results showed that (i) the type of cytopathic effect induced in cell culture seemed to be determined by the UL region, (ii) using the mean time to death in mice as a parameter, markers for virulence were present in the Us and UL regions and (ii) the introduction of deletions in Us strongly reduced the virulence of PRV for pigs. Despite the impaired capacity of the deletion mutants to induce high titres of neutralizing antibodies in the serum, inoculation with mutants derived from NIA-3 prevented clinical disease in pigs upon challenge with the virulent parent strain. These deletion mutants provide a good basis for the production of bioengineered live PRV vaccines.
INTRODUCTION
Pseudorabies virus (PRV) belongs to the class 2 herpesviruses (Honess & Watson, 1977) , and induces an acute and often fatal nervous condition, Aujeszky's dsease (AD), in domestic and wild animals (Baskerville et al., 1973) . The disease has worldwide distribution and is of growing economic importance. In pigs, the natural host of PRV, outbreaks of AD are frequently observed, particularly in regions with a dense pig population. Vaccinations of pigs with modified live and inactivated vaccines are carried out to reduce the economic losses. However, vaccination does not prevent infection and subsequent spread of virulent virus, nor can it prevent the establishment of latent infections (Van Oirschot & Gielkens, 1984b) . The present modified live virus vaccines are generally produced by numerous passages in cell culture and consequently mutations are introduced at random. In addition, most modified live virus vaccines contain several genetic variants . For these reasons there is a need for more immunogenic and better characterized PRV vaccines.
The genome of PRV consists of a 160 kbp linear DNA molecule (Rubenstein & Kaplan, 1975) . A short unique sequence (Us), which is flanked by inverted repeats, is found in two orientations with respect to a unique long sequence (UL) Rixon & BenPorat, 1979 ). Comparison of the genomic structure of virulent PRV strains with those of 0000-7331 © 1987 SGM different avirulent strains by restriction endonuclease mapping revealed the occurrence of deletions in the Us region of most avirulent strains (Gielkens & Berns, 1982; Gielkens et al., 1985 ; Lomniczi et al., 1984) . Two of these avirulent strains (Bartha and Norden) do not code for the glycoprotein gI (Ben-Porat et al., 1986; Mettenleiter et al., 1985b) , a glycoprotein that has been mapped on the wild-type virus genome to the sequences deleted from the vaccine strains (Mettenleiter et al., 1985a) . By using a hybrid PRV derived from the virulent Northern Ireland Aujeszky-3 (NIA-3) and the avirulent NIA-4 strains we have demonstrated that functions involved in virulence are encoded within the Us and/or repeat region of the genome . To define more precisely the genomic regions associated with virulence in pigs we have generated mutants from the NIA-3 strain which carry deletions within the Us region. In this paper we describe the construction of these deletion mutants and their biological properties in cell culture, mice and pigs. Our results demonstrate that these mutants exhibit a strongly reduced virulence, and are highly efficacious in protecting pigs against a severe challenge with virulent PRV.
METHODS
Virus strains. The origin of the NIA-3 and NIA-4 PRV strains has been described (Baskerville et al., 1973) . The viruses were propagated in the established PK-15 cell line or in secondary porcine kidney cells (PK-2) as described (De Leeuw & van Oirschot, 1985) .
DNA and RNA analysis. DNA from PRV-infected PK-15 cells was prepared as follows. The cells were lysed when 70 to 90~ of the monlayer showed a c.p.e., and the DNA was then extracted as described previously (Quint et al., 1981) . Restriction endonuclease digestion of DNA, gel electrophoresis, transfer to nitrocellulose, and hybridizations were carried out as described earlier (Quint et al., 1981 ; van der Putten et al., 1981) .
For the preparation of RNA, baby hamster kidney (BHK) cells were infected with PRV at a multiplicity of 10 p.f.u./cell, and harvested 8 h post-infection. The RNA was purified from the cytoplasmic fraction by two phenol chloroform isoamyl alcohol (50:48:2) extractions and precipitated with ethanol. Poly(A) + RNA was selected by two cycles ofoligo(dT) chromatography. Glyoxal treatment and Northern blot analysis of poly(A) + was carried out by the method of Thomas (1980) .
Construction of deletion recombinant plasmids.
The HindIII-B and BamHI-7 fragment of NIA-3 DNA were cloned in pBR322 according to established procedures. The plasmid pN3B7 (Fig. 1 b) carrying the BamHI-7 was used for the introduction of deletions: pN3B7 was linearized by partial Bali digestion, and full-length DNA molecules were isolated by agarose gel electrophoresis. The linearized DNA was treated with exonuclease BAL-31, and DN A fragments of the desired length (8-3 to 9.0 kbp) were isolated, treated with T4 polymerase, re-ligated and used to transform Escherichia coli H B 101. The size and position of the deletions were determined in a number of transformants. From three recombinant plasmids (Fig. l b) the MluI-BgliI fragments (dashed line) were isolated by agarose gel electrophoresis and ligated into the Mlul BgliI fragment of plasmid pN3HB, carrying the vector and part of the HindIII-B fragment. The resulting recombinant plasmids pHBDelta2.1, pHBDelta2.4, and pHBDelta2.8 were characterized by restriction enzyme analysis and used in the transfection assay.
TransJection. The HindIII inserts of pHBDelta2.1, pHBDelta2.4, pHBDelta2.8 and the HindIII-A fragments of NIA-3 and NIA-4 were co-transfected by the calcium phosphate precipitation technique (Graham & van der Eb, 1973) ; a fourfold molar excess of each of the Hindlll inserts of pHBDelta2.1, pHBDelta2.4 and pHBDelta2.8 plasmids was mixed with the HindlII-A fragment of either NIA-3 or NIA-4 DNA, and the mixtures (500 ng) were precipitated onto PK-2 ceils. The reconstituted viruses obtained from positive transfections were plaque-purified three times.
Biologicalproperties. Parental strains and deletion mutants were examined for the type of c.p.e, induced in cell culture , for virulence in mice (Van Oirschot & Gielkens, 1984a) , for virulence in pigs, and for immunogenicity.
Pigs were obtained from the Dutch Landrace minimal disease herd of the Central Veterinary Institute. To determine the virulence of the mutants for pigs, groups of five 10-week-old seronegative pigs were intranasally inoculated (De Leeuw et al., 1982) with 105 p.f.u, of the parental or mutant strain. The pigs were observed for clinical signs twice daily and rectal temperatures were taken daily. Pigs were given the same food for two daily periods of 20 min, and were weighed three times a week for 3 weeks after inoculation. The above operations were carried out every day at the same time. The mean values for the number of days of growth arrest, fever (body temperature above 40 °C) and virus shedding were calculated from the daily averages of each group. The growth arrest period was defined as the number of days required to regain the group's mean weight of post-challenge day 1. To quantify virus excretion, oropharyngeal fluids (OPF) were collected daily for 10 days after inoculation, by swabbing the interior of the mouth and the pharyngeal area with a sterile gauze wrapped around the tip of a pair of forceps. Brain samples were collected from pigs that died during the experiments and were examined for the presence of virus. Processing and titration of virus in OPF samples and tissue suspensions were as described previously (De Leeuw et aL, 1982) . Isolates were identified by neutralization with a specific PRV antiserum. For titration of neutralizing antibody to PRV, sera were tested in a microneutralization test using PK-2 cells and a serum/virus incubation period of 24 h at 37 °C (Bitsch & Eskildsen, 1976) . Pigs given the deletion mutants were challenged intranasally with l0 s p.f.u of the virulent NIA-3 strain 6 weeks after inoculation. In addition two seronegative pigs of the same age were simultaneously inoculated with the NIA-3 strain. The challenge and the evaluation of the protection induced were done according to our standard procedures (De Leeuw & Van Oirschot, 1985) .
RESULTS

Construction of deletion mutants of NIA-3
Comparison of the genomic structures of the virulent NIA-3 strain and attenuated vaccine strains of PRV revealed the occurrence of deletions within the U s region of various vaccine strains (Gielkens & Berns, 1982; Gielkens et aL, 1985; Lomniczi et aL, 1984) . Hybridization studies using restriction fragments from the Us region showed that sequences present in the NIA-3 strain are absent from the NIA-4 strain and vaccine strains. Therefore the presence of smaller sized BamHI-7-reactive fragments in many of the vaccine strains is due to deletions in this region of the viral genome (Gielkens & Berns, 1982; Gielkens et al., 1985; Lomniczi et al., 1984) (compare lanes 1 and 8 in Fig. 2b ). The deletion in the NIA-4 genome has been localized on the genomic map between the BamHI site at position 0.888 and the BglII site at position 0.856 ( Fig. I a) . In order to prove that deletions in this region are associated with reduced virulence, various deletion mutants of the NIA-3 strain were constructed as outlined in Fig. 1 (b) . Plasmid pN3B7, containing the BamHI-7 fragment of NIA-3 was linearized by partial Bali digestion, treated with exonuclease BAL-31 and recircularized. Three plasmids with different deletions (2.1, 2-4 and 2.8 kbp), which had retained the MtuI site at map unit 0-886 and the BglII site at 0.856 but had lost the MluI site at 0.876, were used for further studies ( Fig. lb and 5a ). In the NIA-3 HindlII-B fragment (plasmid pN3HB) the MluI BglII fragment extending from position 0.886 to 0.856 was replaced by each of the three MluI-BglII fragments isolated from the pN3B7 derivatives. The inserts of the resulting plasmids pHBDelta2.1, pHBDelta2.4, and pHBDelta2.8 were mixed with the HindIII-A fragment of either NIA-3 or NIA-4 and transfected into PK-2 cells. Positive transfections were scored by the occurrence of c.p.e, within 4 days after transfection.
Characterization of deletion mutants
The genomic structure of the reconstituted viruses was analysed by Southern blot analysis. Eight different viruses were compared: the parental strains NIA-3 and N1A-4, the reconstituted NIA-3 strain NIA-3A-3B , and five mutants generated from the deleted NIA-3 HindIII-B fragments and the HindIII-A fragment of either NIA-3 or NIA-4, i.e. 2.1-N3A, 2.4-N3A, 2.8-N3A, 2.1-N4A and 2.4-N4A. Viral DNAs were digested with BamHI, SalI, BamHI + KpnI, and BamHI + KpnI + HindIII, and probed with 32p-labelled NIA-3 DNA or molecularly cloned subgenomic fragments. Fig. 2(a) shows the BamHI pattern of the various genomes after hybridization with 32p_ labelled NIA-3 virus DNA. Comparison of the NIA-3 and NIA-4 pattern (lane 8 and lane 1, respectively) revealed several fragments (7, 10, 12 and 13) which had a differently sized counterpart in the other strain. These BamHI fragments all map in the Us and repeat regions . However, restriction fragment length polymorphisms could also be detected within the UL region. Differences between the UL fragments from NIA-3 and NIA-4 were also evident from blot hybridization of Sa/I-digested DNAs probed with the BamHI-I clone of the Ka strain of PRV (PRV-Ka; Ladin et al., 1982) (Fig. 3, lanes 1 and 8) . These differences between the NIA-3 and NIA-4 genomes were used as markers to confirm the origin of the Us, UL and repeat regions of the various mutant viruses.
Southern blot analysis of the mutant viruses with the cloned BamHI-7 fragment of NIA-3 revealed the presence of a single hybridizing fragment of the expected size (Fig. 2b) 527 confirming their NIA-3 origin (Fig. 2a) . Probing ofBamHI-digested D N A with cloned BamHI-8' revealed the presence of the terminally located BamHI-13 fragment, which was not present in the transfection mixture. The size of the BamHI-13 fragment within the mutant viruses was identical to the size of the BamHI fragment of the parental virus that donated the HindIII-A fragment (Fig, 2c) . The identity of the UL region of the mutant viruses was determined by probing Southern blots of Sa/I-digested viral D N A s with the 32p-labelled BamHI-1 clone (Fig.  3) . The viruses 2.4-N4A and 2. I-N4A (Fig. 3, lanes 2 and 3) , which were generated using the HindIlI-A fragment of NIA-4, showed UL markers characteristic for NIA-4 whereas the other mutated viruses (lanes 4, 5 and 6) possessed NIA-3-specific markers in their UL region. The occurrence of changes at the HindIII site within the inverted repeat region of the mutant viruses was analysed by hybridization of the BamHI-5 probe to KpnI + BamHI (Fig. 4, lanes 9 to 16) and Kpnl +BamHI + HindIII (Fig. 4, lanes 1 to 8) digests of the viral DNAs. The results of the KpnI + BamHI double digestions indicated that all viruses reconstituted in vivo carried a small deletion of about 100 bp in this region. Digestion with HindIII revealed that in approximately half of the mutant viruses the HindlII site was lost (Fig. 4, lanes 1 to 8) , while in two instances (lanes 4 and 5) the virus preparations were not pure and consisted of a mixture of viruses with and without HindlII sites in their repeat units. Upon further plaque purification the two genotypes segregated. The presence of the same alteration in both repeats and the identity of the BamHI-13 fragment supports the notion that the terminal repeat can be regenerated from the internal repeat by homologous recombination or a copying mechanism , Roizman et al., 1978 . 
Identification of RNAs transcribed from the BamHI-7 region
The m R N A species accumulating in BHK cells infected with 2.4-N3A, 2.8-N3A, NIA-3 or NIA-4 were characterized by Northern blot analysis. 
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2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 K Fig. 4 . Characterization of deletions in the repeat regions of the hybrid viruses. Viral DNA (1 ~tg) was digested by KpnI + BamHI (lanes 9 to 16) and KpnI + BamHI + HindIII (lanes 1 to 8) and hybridized with a 32P-labelled BamHI-5 clone. The lanes represent DNA from different viruses: lanes 1 and 9, NIA-4; lanes 8 and 16, NIA-3; lanes 7 and 15 (see also legend Fig. 2 ), NIA-3A-3B; lanes 2 and 10, 2.4-N4A; lanes 3 and 11,2.1 -N4A; lanes 4 and 12, 2.8-N 3A; lanes 5 and 13, 2.4-N 3A; lanes 6 and 14, 2.1-N3A. Size markers as in Fig. 2 . 529 R N A from cells infected with the wild-type virus NIA-3 revealed the presence of nine major m R N A size classes ranging from 1.0 to 5.5 kb (Fig. 5b, left autoradiograph, lane 1) . In poly(A) + R N A preparations from cells infected at the same time with 2.4-N3A, 2.8-N3A and NIA-4 a less complex pattern was seen. Some of the m R N A s appeared unique to particular deletion mutants (same autoradiograph, lanes 2 to 4).
In order to obtain more insight into the location of the different transcription units, the same samples were hybridized with the three PvuI subfragments A, B and C, derived from the BamHI-7 fragment (Fig. 5a) . No R N A transcripts were detected with the PvuI-A fragment in cells infected with the NIA-4 strain (Fig. 5 b, second panel, lane 4) , whereas the PvuI-B fragment did not hybridize with transcripts from cells infected with the 2.8-N3A strain (Fig. 5b, third  panel, lane 3) . The absence of hybridization of labelled PvuI-A and PvuI-B fragments to R N A from cells infected with NIA-4 and 2.8-N3A, respectively, is consistent with the position of the deletions in these strains (Fig. 5a) . 
Biological characterization o f deletion mutants
The parental strains NIA-3 and NIA-4, and the deletion mutants 2 . 4 -N 3 A , 2 . 8 -N 3 A and 2 . 4 -N 4 A were examined with respect to their biological properties in cell culture, mice and pigs.
Cell cultures infected with P R V usually show one of two types of c.p.e. : either pronounced syncytium formation or rounding of cells (Kaplan, 1969) . P R V isolates inducing an intermediate type of c.p.e, have also been reported (Bitsch, 1980) . In this study, the virulent NIA-3 strain and the NIA-3-derived deletion mutants 2 . 4 -N 3 A and 2 . 8 -N 3 A produced an intermediate type of c.p.e, in which both syncytia and rounded cells of variable sizes were present (Table 1 ). The 1.14 * The growth arrest period is defined as the number of days needed to regain the group's mean weight at the first day after inoculation. Pigs that died were not included in this calculation.
t Mean number of days during which body temperatures were above 40 °C. :~ Percentage positive virus-containing OPF samples collected during the first 10 days after inoculation. § Mean virus titre expressed as log~o p.f.u, of virus per g of fluid.
II Antibody titre at day 21 post-infection is expressed as logt0 of the reciprocal of the final serum dilution inhibiting c.p.e, in 50% of the cultures.
¶ yD, Not determined.
NIA-4 strain and the mutant 2.4-N4A induced a c.p.e, which was characterized by rounding of cells. It appeared that the origin of the UL region determined the type of c.p.e, induced in cell culture; mutants with the HindIII-A fragment of NIA-3 gave rise to intermediate types of c.p.e., whereas mutants containing the HindIII-A fragment from NIA-4 produced a c.p.e, with rounding of cells. The mean time to death (MTD) in mice upon inoculation with strains of PRV has been used as a parameter to group strains according to virulence (Platt et al., 1980) . In general, virulent PRV kills mice faster than attenuated strains, although exceptions have been noted (Van Oirschot & Gielkens, 1984a) . As can be seen from Table 1 , the MTDs of the different strains varied considerably. The deletion mutants (2.4-N3A and 2.8-N3A) exhibited significantly (Wilcoxon rank test, P < 0.05) longer MTDs than the NIA-3 strain, indicating that a marker for virulence in mice was present in the Us region. Also the difference in MTDs for mutants 2.4-N3A and 2.8-N3A was significant (Wilcoxon rank test, P < 0.05), suggesting that the virulence for mice is influenced by the position and/or length of the deletion in the Us region.
Comparison of the MTDs of 2.4-N3A and 2.4-N4A clearly demonstrated that markers for virulence in mice are present also in the UL region of the viral genome. PRV was recovered from brain tissues of all mice that died, and analysis of these virus isolates showed the presence of the expected mutant genotypes. Virulence of the deletion mutants was also determined in pigs, the natural host of PRV. As shown in Table l , the parental NIA-3 strain killed two of five pigs, and survivors showed severe signs of AD. In contrast, the deletion mutants of NIA-3 showed a considerably reduced virulence for pigs, as evidenced by the absence of mortality and growth arrest, and a strong reduction of the period of fever. In addition, virus excretion in OPF was strongly diminished in pigs given the NIA-3-derived deletion mutants. The virulence of the NIA-4 did not change when its HindIII-B fragment was replaced by the NIA-3 HindIII-B fragment with a deletion of 2.4 kbp. This would be expected if the deletion in the Us region of NIA-4 is the major factor in determining the reduced virulence of the NIA-4 strain. These results indicate that the deletions in the Us region of PRV are associated with reduced virulence in both mice and pigs.
The 2.4-N3A and 2,8-N3A mutants had an impaired capacity to induce high titres of neutralizing antibodies in pigs (Table i) . However, pigs inoculated with these deletion mutants were well protected against a challenge with virulent PRV. Inoculation with the deletion mutants prevented clinical signs, growth arrest and fever upon challenge with the virulent NIA-3 strain (Table 2 ). Pigs inoculated with mutant 2.4-N4A developed fever. Although protected * The challenge and the evaluation of the protection induced were according to our standard procedures (De Leeuw & van Oirschot, 1985) , outlined in Methods.
} Antibody titres at day 42 after inoculation are expressed as the reciprocal of the final serum dilution inhibiting c.p.e, in 50~ of the cultures.
:~ See Table 1. against clinical illness, most pigs shed virus after challenge. However, in comparison with control pigs the percentage of virus-containing samples collected for 10 days after challenge was markedly reduced. In addition the mean titres of PRV in OPF samples were 103-to 105-fold lower than in control pigs (Table 2 ). In particular, mutant 2.4-N3A reduced virulent virus excretion considerably. In two pigs vaccinated with this mutant no shedding of virulent virus could be detected.
DISCUSSION
We have shown previously that replication-competent PRV genomes can be regenerated from subgenomic fragments . Obviously, this also allows the introduction of mutations in PRV, in a single step by co-transfection of manipulated subgenomic fragments. This approach does not require in vivo selection procedures using mutagenic agents, and therefore the probability of introducing mutations that may obscure the effects of the 'designed' deletions is expected to be very low. Evidence for a low incidence of mutagenesis has been obtained from biological tests in both mice and pigs, performed with reconstituted wild-type viruses from NIA-3A and 3B co-transfection experiments .
We have chosen the Us region of PRV as a target to introduce deletions. We wanted to investigate whether the reduced virulence of the classical vaccines could be caused by the occurrence of deletions in the Us region (Gielkens et al., 1984 Lomniczi et al., 1984) and whether the site and size of the deletion were associated with distinct biological properties. Transfection of the HindlII-B fragment of NIA-3 carrying a defined deletion, together with the HindlII-A fragment into PK-2 cells resulted in the generation of replication-competent viruses carrying the expected deletion in the Us region. The deletion mutants 2.4-N3A and 2.8-N3A e~hibited distinct properties, both with respect to the mRNAs transcribed from the Us region and their virulence for mice and pigs. The influence of the deletions on gene expression was illustrated by Northern blot analysis of viral mRNAs transcribed from the Us region of the viral DNA. Upon infection of cell cultures each deletion mutant gave rise to a characteristic set of mRNAs: some mRNAs present in cells infected with the wild-type virus were absent, whereas differently sized mRNAs were generated (compare lanes 1, 2, 3 and 4 in Fig. 5a ). It is likely that the glycoprotein gI transcription unit is truncated in the deletion mutants. For two other vaccine strains, Bartha and Norden, it has been found that gI (Ben-Porat et al., 1986; Mettenleiter et al., 1985 b) is not synthesized in infected ceils and that gI maps on the wild-type genome to the region deleted in our mutants. Experiments are in progress to determine the alterations at the protein level.
The presence of deletions in the Us region profoundly influenced the biological properties of virulent PRV. The deletion mutants had a reduced virulence for mice and, in particular, for pigs. The marked decrease in virulence for pigs can be attributed mainly to the deletions in the Us region, because the small deletions at the HindlII site within the repeat regions only slightly affected virulence for pigs . The mutants showed a diminished ability to grow in the upper respiratory and/or digestive tracts, as evidenced by the low virus titres in oral secretions. Nevertheless, in some cell cultures (e.g. PK-15) the deletion mutants reached maximum titres similar to that of the parental N IA-3 strain, indicating that in this ceil type the deleted regions have no essential function in the replication process. Comparable results were described for the Bartha vaccine strain (Ben-Porat et al., 1986) . Both the virulence and the immunogenicity were reduced in the deletion mutants as compared to the parental strain. Neutralizing antibody titres were more than tenfold lower. In spite of this impaired immunogenic capacity, the deletion mutants proved to be highly protective in pigs. Intranasal inoculation with 105 p.f.u, of the NIA-3 mutants completely protected the pigs against growth arrest and the development of fever following challenge with virulent PRV. These pigs appeared to be better protected against challenge than those given 106 p.f.u. (a tenfold higher dose) of the Bartha strain of PRV, which is one of the most efficacious PRV vaccines (De Leeuw & Van Oirschot, 1985) . Pigs surviving an infection with the parental NIA-3 strain did not shed virus after re-infection with the homologous strain , The mutants were unable to prevent the shedding of challenge virus completely. However, virus excretion after challenge was reduced to very low levels, in particular in pigs given the 2.4-N3A mutant. This mutant completely prevented the shedding of challenge virus in two of five pigs. The reduction of virulent virus excretion is of considerable significance with regard to elimination of field virus circulation.
Since the inactivation of genes associated with virulence has been accomplished by the introduction of large deletions, reversion to virulence may only occur after recombination with PRV strains with an intact Us region. Although this is not likely to occur in vivo, it may contribute to the safety of the deletion mutants for use as vaccines of multiple deletions were present in various regions of the genome, each contributing to a reduction in virulence. Therefore we are currently generating mutant viruses with additional deletions in other regions of the genome.
